Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1988 | 12-1987 | 09-1987 | 06-1987 | 03-1987 | |
| Sales | 150 | 0 | 0 | 0 | 0 |
| Gross Profit | 150 | 0 | 0 | 0 | 0 |
| Operating Expenses | 4,444 | 3,663 | 2,628 | 2,647 | 1,825 |
| Operating Income | -4,295 | -3,663 | -2,628 | -2,647 | -1,825 |
| Interest Expense | 3 | 2 | 7 | 0 | 0 |
| Other Income | 0 | 101 | 127 | 147 | 43 |
| Pre-tax Income | -4,298 | -3,565 | -2,509 | -2,500 | -1,782 |
| Net Income Continuous | -4,298 | -3,565 | -2,509 | -2,500 | -1,782 |
| Net Income | $-4,298 | $-3,565 | $-2,509 | $-2,500 | $-1,782 |
| EPS Basic Total Ops | -42,982.00 | N/A | -25,089.00 | -25,003.00 | -17,815.00 |
| EPS Basic Continuous Ops | -42,982.00 | N/A | -25,089.00 | -25,003.00 | -17,815.00 |
| EPS Diluted Total Ops | -42,982.00 | N/A | -25,089.00 | -25,003.00 | -17,815.00 |
| EPS Diluted Continuous Ops | -42,982.00 | N/A | -25,089.00 | -25,003.00 | -17,815.00 |
| EBITDA(a) | $-4,295 | $-3,663 | $-2,628 | $-2,647 | $-1,825 |